Clinical Trial

Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-26.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-06-29
Trial Details
NCT Number NCT07197775
Lead Sponsor Endogenex, Inc.
Conditions Type 2 Diabetes Mellitus (T2DM), Type2Diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes
Enrollment 500 participants
Start Date 2026-03-11
Primary Completion 2032-05 (estimated)
Study Completion 2032-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-01